1 Start 2 Complete InstructionsPlease complete the Module 2: Obesity Management Follow-up Survey and tell us what you learned from this module. Your response is important, and will be used to demonstrate the value of this educational program and to guide development of future CME activities. Thank you for your participation. Please provide your email so we can contact you with promotional information including drawings and prizes for completing this survey. This is optional. For individuals of South Asian descent, which of the following BMI levels meets the population definition for obesity? * BMI >40 kg/m2 BMI >30 kg/m2 BMI >25 kg/m2 BMI >23 kg/m2 Which of the following is NOT a biological adaptation to weight reduction? * Increased appetite Increased satiety Increased ghrelin Decreased leptin and insulin According to current guidelines, which of the following criteria is an indication for obesity pharmacotherapy? * BMI ≥25 with obesity-related comorbidity BMI ≥26 with obesity-related comorbidity BMI ≥27 with obesity-related comorbidity The current treatment gap in obesity management refers to: * There are no safe and effective obesity treatments Diet, lifestyle, and conventional obesity drugs are not effective enough for many people Bariatric surgery is too risky for most people There is no available treatment that leads to substantial (>10%) weight loss Which of the following types of bariatric surgeries is most efficacious in promoting weight loss? * Sleeve gastrectomy Gastric bypass Lap band All types of bariatric surgery are equally effective Which of the following factors are part of the Fibrosis-4 (FIB-4) Index? * Age, diabetes, AST-to-ALT ratio, BMI Age, BMI, diabetes, and platelet Age, AST, ALT, platelet, and impaired fasting glucose Age, AST, ALT, and platelet How many patient encounters have you had in the last 90 days? * <200 200 400 600 800 1000 1200 >1200 As a result of this educational activity, did you make any changes to your clinical practice? * Yes No What specific changes did you make to your practice as a result of information received in this activity? (Select all that apply) * Utilize open communication techniques to initiate the conversation about obesity management Adequately screen patients for obesity Consider obesity pharmacotherapy or metabolic surgery when appropriate in addition to lifestyle modifications for obesity management Consider the presence of NAFLD or NASH in patients with obesity and/or other cardiometabolic risk factors Schedule obesity-specific follow-up visits if feasible or refer adequately as appropriate What additional improvements have you made in your clinical practice after participating in this activity? * What barriers are currently preventing you from making these changes? (select all that apply) * Formulary restrictions Insurance/financial issues Time constraints Lack of interprofessional team support System constraints Treatment related adverse events Patient adherence/compliance None Were the changes that you made in clinical practice beneficial to patient care?* * Yes No Has this course improved the comprehensive treatment of your patients with cardiometabolic disease or cardiometabolic risk? * Yes No Please explain your above answer. * Leave this field blank
